Article Excerpt: A groundbreaking new drug is the latest development in the fight against opioid addiction offering new hope to drug users. Buvidal, an injectable form of Buprenorphine, acts as a slow-release drug and blocks the opioid receptors in the brain which stops the patients from having withdrawal symptoms. It only has to be administered once a week or once a month, making it a good alternative to methadone which is often prescribed to wean users off of heroin and other opioids.
Full Article: https://tinyurl.com/y5tszsl7
Article Source: Business Insider